Gene · 835
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-34a: A Novel Therapeutic Target in Fibrosis. | Front Physiol | 2022 | 35795649 | PubTator, text mining | PubMed |
| The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion. | J Invest Dermatol | 2022 | 35787399 | PubTator, text mining | PubMed |
| A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells. | J Biol Chem | 2022 | 35764172 | PubTator, text mining | PubMed |
| Factors that influence older patients' participation in clinical communication within developed country hospitals and GP clinics: A systematic review of current literature. | PLoS One | 2022 | 35759474 | PubTator, text mining | PubMed |
| Global cellular response to chemical perturbation of PLK4 activity and abnormal centrosome number. | Elife | 2022 | 35758262 | PubTator, text mining | PubMed |
| Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells. | Int J Mol Sci | 2022 | 35743086 | PubTator, text mining | PubMed |
| A Quantitative Proteomic Approach Explores the Possible Mechanisms by Which the Small Molecule Stemazole Promotes the Survival of Human Neural Stem Cells. | Brain Sci | 2022 | 35741576 | PubTator, text mining | PubMed |
| Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response. | Cells | 2022 | 35741016 | PubTator, text mining | PubMed |
| Influence of Inhibition of COX-2-Dependent Lipid Metabolism on Regulation of UVB-Induced Keratinocytes Apoptosis by Cannabinoids. | Biomolecules | 2022 | 35740969 | PubTator, text mining | PubMed |
| Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias. | Front Pharmacol | 2022 | 35734412 | PubTator, text mining | PubMed |
| Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir. | J Med Chem | 2022 | 35731933 | PubTator, text mining | PubMed |
| Identification of specific role of SNX family in gastric cancer prognosis evaluation. | Sci Rep | 2022 | 35715463 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Correction: Caspase-2 regulates S-phase cell cycle events to protect from DNA damage accumulation independent of apoptosis. | Oncogene | 2022 | 35705736 | PubTator, text mining | PubMed |
| Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins. | Cell Rep | 2022 | 35705054 | PubTator, text mining | PubMed |
| The Remarkable Selectivity of Nirmatrelvir. | ACS Pharmacol Transl Sci | 2022 | 35702394 | PubTator, text mining | PubMed |
| Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35693293 | PubTator, text mining | PubMed |
| Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia. | Cell Death Discov | 2022 | 35690610 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| An epigenome-wide view of osteoarthritis in primary tissues. | Am J Hum Genet | 2022 | 35679866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/835/papers?page=23